- JULPHAR

Abu Dhabi Securities Exchange (United Arab Emirates)
0.93 Last Update 20/09/2024 10:48 KSA
× lblWarning! {{companyMessage}}
  • :0.93
  • :0.93
  • ('000):1,155,228
  • (AED '000):1,074,362
  • :0.2


  • 457,197
  • :9,925
  • :46.07
  • 52-W L52-W H
    0.93
    0.71.62
  • 14.20%
  • 98.29%


  • 37

  • (AED):

    421,796.17
  • (AED):19,818,445
  • :0.02
  • Performance Comparison

Activities

Gulf Pharmaceutical Industries (Julphar) is one of the largest pharmaceutical manufacturers in the Middle East and Africa. Established in 1980 under the guidance of Sheikh Saqr Bin Mohammed Al Qasimi, the late ruler of Ras Al Khaimah, Julphar has grown to become a key player in the global pharmaceutical industry. Julphar's mission is to provide high-quality, innovative, and affordable healthcare solutions. The company produces a wide range of medicines, vaccines, and consumer healthcare products targeting major therapeutic segments such as diabetes, gastrointestinal tract (GIT), respiratory, pain management, wounds and scars, anti-infectives, anemia, gynecology, dermatology, erectile dysfunction, and cardiology. The company operates 12 internationally accredited manufacturing facilities capable of producing up to one million boxes of medicine per day. In 2012, Julphar became one of the world's largest producers of insulin, thanks to its state-of-the-art biotechnology facility in the UAE. Julphar employs around 3,400 people and distributes its products to more than 30 countries across five continents. The company is also listed on the Abu Dhabi Securities Exchange (ADX) since 2005.

  • Chairman:
    Shk. Saqer H. Al-Qasimi
  • Vice-chairman:
    Rabih Khouri
  • CEO:
    Basel N. A. Ziyadeh
  • Board Members:

    Abboud Bejjani

    Abdulaziz A. Al-Zaabi

    Hamody A.H. Al-Limy

    Jean Diab

    Medhat M. A. Al-Gamal

    Olfa Gam

    Raman Garg

  • Auditors:

    Ernst & Young

Chief HR

Gopa Kumar

Chief Commercial Officer

Amgad Thabet

Chief Financial Officer

Ignacio Anglada

Chief Corporate Development and Strategy Officer

Juergen Lauterbach

Chief Technical Officer

Malik Metahri
Julphar named top pharma company in UAE (Trade Arabia - 04/04/2018)

Julphar, a leading pharmaceutical manufacturer in the region, has been ranked as the number one pharmaceutical ...

Read More ...

Julphar records Dh1.3b in turnover for 2017 (Gulf News - 07/03/2018)

Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, recorded sales ...

Read More ...

Julphar posts Dh86m in third-quarter profit (Gulfnews - 20/11/2017)

Julphar Gulf Pharmaceutical Industries on Sunday said its net profit for the third quarter of this ...

Read More ...

Read More ...
Announced On Period As Of Net Profit (SAR Mil) Growth (%)
14/11/2024 9-Month 30/09/2024 -07 0
15/08/2018 6-Month 30/06/2018 51 -23.34
16/05/2018 3-Month 31/03/2018 20 -56.25
14/02/2018 12-Month 31/12/2017 90 -57.43
12/11/2017 9-Month 30/09/2017 89 -44.11
Market Cap
US$ Mil
Last Price
Local Cry
Price Change (%)
1 Day
Price Change (%)
1 Year
P/E TTM P/B MRQ Dividend Yield (%) Beta ROA (%) ROE (%)
SULAIMANALHABIB 27,049.75 291.8 0.62 0 46.65 0 0 0 0 0
PUREHEALTH 11,069.47 3.66 1.1 0 0 0 0 0 0 0
MOUWASAT 5,218.07 98.1 0.2 0 29.45 0 0 0.81 0 0
NAHDI 4,469.21 130 0.77 0 19.41 0 0 0 0 0
DALLAHHEALTH 4,113.05 160.4 1.51 0 34.79 0 0 0.93 0 0
FAKEEHCARE 3,616.94 59.5 1.7 0 49.56 0 0 0 0 0
JAMJOOMPHARMA 3,130.31 167.2 -0.36 0 35.42 0 0 0 0 0
CARE 2,270.98 184 -3.16 0 29.63 0 0 0.85 0 0
SAUDIGERMANHEALTH 1,793.05 73 -0.14 0 33.16 0 0 0.79 0 0
SPIMACO 989.78 31.8 2.74 0 -904.97 1.41 0 0.91 8.47 15.11
AVALONPHARMA 704.63 135.2 2.26 0 33.28 0 0 0 0 0
MIDAN 528.86 796 6.98 0 28.42 1.39 0 0 12.06 17.87
EQUIPMENTHOUSE 417.34 52.3 0.19 0 32.84 0 0 0 0 0
AYYAN 403.37 15 -0.27 0 -6.52 0 0 0.81 0 0
MCGS 352.6 4.55 -1.11 -27.12 19.71 0.13 5.86 0.98 4.88 6.49
GMPC 351.95 1.85 -2.12 -27.2 0 0.98 3 -0.08 75.81 111.42
BURJEEL 342.87 2.42 4.76 0 0 0 0 0 0 0
JULPHAR 284.74 0.93 0 4.35 -19.06 0.45 5.27 0.2 4.09 0
ATC.KSE 214.09 435 0 13.4 7.3 1.32 1.82 -0.01 2.93 12.88
RPM 195.98 3.6 -1.1 0 0 0 0 0 0 0
QGMD 48.31 1.54 0.19 -41.73 0 0 0 0.76 0 0